Blazing Star Merger Sub completes Walgreens debt tender offer
Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. (NASDAQ:TEM), recently sold a significant portion of his holdings in the company. According to a recent SEC filing, Lefkofsky disposed of shares worth approximately $41 million over the course of two days, March 5 and March 6, 2025. The sale comes as InvestingPro data shows the stock has declined about 13% over the past week, with shares currently trading at $49.10, down from $53.06.
The transactions involved the sale of Class A Common Stock, with prices ranging from $48.85 to $52.96 per share. The sales were conducted through Gray Media, LLC and Blue Media, LLC, entities controlled by Lefkofsky. Following these transactions, Lefkofsky continues to hold substantial shares in Tempus AI, with over 9.4 million shares remaining under Gray Media, LLC and over 25.8 million shares under Blue Media, LLC. The company, currently valued at $8.4 billion, has shown strong revenue growth of 30% in the last twelve months.
These transactions were made in accordance with a pre-established Rule 10b5-1 trading plan, which allows company insiders to sell a predetermined number of shares at a set time, helping to avoid accusations of insider trading. According to InvestingPro, which rates Tempus AI’s overall financial health as FAIR, the company maintains strong liquidity with current assets exceeding short-term obligations. Discover more insights about TEM and access the comprehensive Pro Research Report, available for 1,400+ top US stocks.
In other recent news, Tempus AI Inc reported a 35.8% increase in fourth-quarter revenue for 2024, reaching $700 million. This substantial growth was accompanied by an earnings per share (EPS) of -0.18. The company has also raised its 2025 revenue guidance to approximately $1.24 billion, factoring in contributions from its recent acquisition of Ambry Genetics. Despite the impressive revenue figures, JPMorgan has downgraded Tempus AI’s stock from Overweight to Neutral, though it raised the price target to $55.00, citing the stock’s current valuation as fully valued relative to its peers.
Stifel analysts maintained a Hold rating on Tempus AI, with a price target of $65.00, following the company’s earnings announcement. They noted the company’s strong growth prospects but considered the stock’s valuation fair compared to industry standards. Tempus AI’s forecast suggests a robust 30% growth in core revenue, aligning with current consensus estimates. The company also launched the Olivia AI personal health app, expanding its product offerings. These developments reflect Tempus AI’s strategic initiatives and its positioning for future growth in the diagnostics and AI sectors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.